Human Data Logo
NBDC HumanDB
NBDC Research ID:hum0006-v3
Release info
To the latest version (v6)

Title

Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance

Research overview

Aims: The identification of genomic/genetic alterations in brain tumors (gliomas) and analysis of their clinicopathological significance. Brain tumors are diseases with a very poor prognosis and recurrence is almost inevitable even with multidisciplinary treatment. Therefore, it is important to elucidate genetic aberrations associated with the development or malignant transformation of brain tumors. In this study, we will comprehensively analyze molecular landscapes in brain tumors. We will also investigate how these are involved in the response to various therapies to establish new molecular therapies for brain tumors. In addition, we will develop new diagnostic methods and biomarkers by comparing clinicopathological information with molecular profiles and analyze the relationship between diagnosis, prognosis prediction, and therapeutic response prediction using bioinformatics and artificial intelligence.

Methods: Exome sequencing, RNA sequencing and Methylation array were performed. Matched normal DNA was also used for Exome sequencing. Targeted DNA sequencing for vascular malformation samples was conducted to investigate somatic mutations. FLeCS-seq, SMART-seq, RNA-seq, short-read WGS, and ultralong-read WGS analyses for normal left frontal lobe tissues were performed.

Targets: Surgical specimen obtained from 6 patients with astrocytoma (primary and matched recurrent samples) and paired normal peripheral blood cells (total: 23 samples). Surgical specimen obtained from 16 patients with oligodendroglioma (12 primary and matched recurrent samples, 8 samples obtained from 4 patients by multi-sampling) Surgical specimen obtained from patients with gliomas (17 patients with diffuse cerebellar glioma, 8 patients with cerebral glioblastoma and 14 patients with thalamic glioma) Surgical specimen obtained from 94 patients with gliomas, including primary and matched recurrent samples (total 114 samples) and paired normal blood cells Twelve cerebral cavernous malformations, 1 vertebral hemangioma, 3 orbital cavernous malformations, and respective paired peripheral blood samples Normal left frontal lobe tissues from a patient with glioma

Datasets

Dataset ID
Access type
Type of data
Release date
JGAD000004Controlled-access (Type I)astrocytoma NGS (Exome)2020-09-28
JGAD000106Controlled-access (Type I)astrocytoma NGS (Exome)2020-09-28
JGAD000112Controlled-access (Type I)gliomas (diffuse cerebellar glioma, cerebral glioblastoma, thalamic glioma) NGS (Exome, RNA-seq), Methylation array2020-09-28
JGAD000107Controlled-access (Type I)astrocytoma NGS (Exome)2020-09-28
JGAD000113Controlled-access (Type I)gliomas (diffuse cerebellar glioma, cerebral glioblastoma, thalamic glioma) NGS (Exome, RNA-seq), Methylation array2020-09-28
JGAD000108Controlled-access (Type I)astrocytoma NGS (Exome)2020-09-28
JGAD000114Controlled-access (Type I)gliomas (diffuse cerebellar glioma, cerebral glioblastoma, thalamic glioma) NGS (Exome, RNA-seq), Methylation array2020-09-28

Data provider

    Representative
    Nobuhito Saito
    Organiation
    Department of Neurosurgery, The University of Tokyo

Research projects

Name
URL
Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)https://p-direct.jfcr.or.jp/english/

Grants

Name
Title
Project number
KAKENHI Grant-in-Aid for Scientific Research (B)Analysis of novel vascular malformation causative gene
  • 21H03041
Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Japan Agency for Medical Research and Development (AMED)Development of novel therapeutic strategy and biomarker for the treatment of malignant brain tumors
    Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED)Analysis of the mechanisms for development of tumor heterogeneity related to treatment resistance of gliomas and discovery of therapeutic strategies

      Related publications

      Title
      DOI
      Datasets
      Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Gliomahttps://doi.org/10.1126/science.1239947
      Genetic and epigenetic stability of oligodendrogliomas at recurrencehttps://doi.org/10.1186/s40478-017-0422-z
      Distinct molecular profile of diffuse cerebellar gliomashttps://doi.org/10.1007/s00401-017-1771-1
      DNA demethylation is associated with malignant progression of lower-grade gliomashttps://doi.org/10.1038/s41598-019-38510-0
      Somatic GJA4 gain-of-function mutation in orbital cavernous venous malformationshttps://doi.org/10.1007/s10456-022-09846-5

      Controlled access users

      Name
      Organiation
      Country
      Research title
      Period of data use
      Datasets
      Attenello FrankUSC Keck School of MedicineUSAExamining the role of a novel long noncoding RNA, linc02454, in resistance of glioblastoma to temozolomide2023-04-062026-02-01
      Hamada MichiakiWaseda UniversityJapanConstruction of RNA-targeted Drug Discovery Database2023-01-052027-10-31
      Alvarez NehemiahDe Novo Genomics CorporationUSAEvolutionary conservation of gene expression and epigenetic analysis of trophoblast stem cells2018-01-152021-03-19